Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group.
about
The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviewsGuidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated PneumoniaNeuraminidase inhibitors for preventing and treating influenza in healthy adults and childrenNeuraminidase inhibitors for preventing and treating influenza in healthy adults and children - a review of clinical study reportsNeuraminidase inhibitors for preventing and treating influenza in healthy adultsNeuraminidase inhibitors for preventing and treating influenza in healthy adultsPerspectives on antiviral use during pandemic influenzaNeuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysisCurrent and future antiviral therapy of severe seasonal and avian influenzaComparison of the MChip to viral culture, reverse transcription-PCR, and the QuickVue influenza A+B test for rapid diagnosis of influenzaIdentifying research priorities on infections in older adults: proceedings of an interdisciplinary workshopRole of Autophagy and Apoptosis in the Postinfluenza Bacterial PneumoniaPeramivir: A Novel Intravenous Neuraminidase Inhibitor for Treatment of Acute Influenza InfectionsVirus-induced secondary bacterial infection: a concise reviewAntibody-Based Strategies to Prevent and Treat InfluenzaViral-bacterial interactions-therapeutic implicationsUsing the Ferret as an Animal Model for Investigating Influenza Antiviral EffectivenessNeuraminidase inhibitors for influenza B virus infection: efficacy and resistanceSafety and efficacy of peramivir for influenza treatmentOseltamivir Population Pharmacokinetics in the Ferret: Model Application for Pharmacokinetic/Pharmacodynamic Study DesignA drug-disease model describing the effect of oseltamivir neuraminidase inhibition on influenza virus progression.Supply of neuraminidase inhibitors related to reduced influenza A (H1N1) mortality during the 2009-2010 H1N1 pandemic: summary of an ecological study.Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and preventionBinding of a natural anthocyanin inhibitor to influenza neuraminidase by mass spectrometryRWJ-270201 (BCX-1812): a novel neuraminidase inhibitor for influenzaIn vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants.Neuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spreadEfficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trialInfluenza pandemic waves under various mitigation strategies with 2009 H1N1 as a case studySupply of neuraminidase inhibitors related to reduced influenza A (H1N1) mortality during the 2009-2010 H1N1 pandemic: an ecological studyTreating and preventing influenza in aged care facilities: a cluster randomised controlled trialImpact of different oseltamivir regimens on treating influenza A virus infection and resistance emergence: insights from a modelling studyThe Tamiflu fiasco and lessons learntEffect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trialEffectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in ChinaEstimating the United States demand for influenza antivirals and the effect on severe influenza disease during a potential pandemic.Ebola virus disease: roles and considerations for pharmacists.Effects of influenza antivirals on individual and population immunity over many epidemic waves.Can antiviral drugs contain pandemic influenza transmission?
P2860
Q21090775-68C14D21-2387-4551-B90E-9E9CDFC83A41Q22241905-D8D8045C-588F-4629-82FC-08D46A4765DCQ24203905-5542ABB8-40B6-4946-A457-E3DC306CA24DQ24235164-83A566D7-73EC-4DA4-8BFB-FC3DA3DCFDF2Q24240097-7E428DBA-AA63-4719-B549-724A656E65D5Q24244898-F8C17CF7-2FC8-469C-A795-095BAB22F2BFQ24522384-505212AC-6D8D-494F-8F7B-AFBBC7130533Q24644585-7677DCB7-D045-4F97-B45F-7604CEBF50C2Q24656164-A9CA22CD-C42A-4D2E-A2FC-0781E9E31950Q24672633-067D298E-ADF5-49E8-B3A6-0D3EA10B399AQ24803393-C43572AE-240C-47C7-BA1C-E74E23EC6EBEQ26744768-A9E83256-FFE7-42A7-8F5E-236A2FDB92CEQ26749578-112F2860-2C1F-4621-A541-DE89596C528DQ26783333-AD75197C-2D71-42B4-ABF2-68E8161430E0Q26798520-9A930BFE-D587-46B9-AC0E-9339C1B2EB79Q26825261-6D3ED57E-74BA-4E44-8098-16CC3C388A62Q27000668-1483188A-D034-4CC0-B09B-0783304FBB87Q27021579-1680CC7B-2868-4E2B-A2C9-C243FDC81E8CQ27027408-0814C4CF-4830-4FD2-83BD-CB0486B39A6AQ27317735-7F9708BC-2A75-4EBA-96EC-04D962CA234FQ27324423-FDD37F8E-6BFC-4CBC-9C59-974E3F9F2117Q27687868-0AABB26C-9AB6-42B7-A3FB-9946CBFF9453Q28201389-02A0BFB1-93D0-4AFD-8E09-D3D96F550BD7Q28292279-CAB658DB-C402-4F46-A7CD-F60DB211D354Q28344592-92709256-3AD5-4807-AB8B-DEC7D0C911B5Q28349519-EC24CFD2-D7F9-4987-A6E0-1F4E10EF97B2Q28364114-D9ED3795-FFC3-4A03-80C2-057559AF6229Q28471814-2405B6F9-531B-4D8C-937F-00C43C0A24C6Q28475986-86C1684D-A422-43C4-9A8C-9C8B7AC77E4EQ28476585-BAEFA2E9-B58A-4829-B8D6-B001BE68A4FFQ28483664-8CE1CBFA-7AB8-42EA-A967-F44B1687BC40Q28484471-46BD4400-AE7A-459B-B36D-4B745F732426Q28537982-24083D83-5E34-4D7B-96F8-E1ABAA511A6CQ28545064-A0F9D4FD-BD1E-4FD5-8281-54F105E84F75Q28684866-6D3120A6-C1D3-4D94-9007-9F97F1DB9442Q28749090-068BD720-9B57-41B3-A84E-6B61A3D3B863Q30204152-BD5D3438-6AC7-423B-AEE0-7C18474A16A1Q30206102-C441E6A8-3F37-4E74-AA0F-9617B0763864Q30224681-E30F677C-50E3-445B-B38D-7727B94286D3Q30226617-B6A95FE7-542B-49B1-8533-FD3DE626500D
P2860
Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Efficacy and safety of the ora ...... ral Neuraminidase Study Group.
@en
type
label
Efficacy and safety of the ora ...... ral Neuraminidase Study Group.
@en
prefLabel
Efficacy and safety of the ora ...... ral Neuraminidase Study Group.
@en
P2093
P356
P1476
Efficacy and safety of the ora ...... ral Neuraminidase Study Group.
@en
P2093
F G Hayden
J J Treanor
N Kinnersley
P S Vrooman
R Barbarash
P304
P356
10.1001/JAMA.283.8.1016
P407
P577
2000-02-01T00:00:00Z